Showing results (161-170 of 186) with videos related to
Sort By:
Pageof 19
Plos One|February 29, 2024
Evaluation of COVID-19 antigen rapid diagnostic tests for self-testing in Lesotho and ZambiaMoniek Bresser, Rahel Milena Erhardt, Kwame Shanaube, et al.Plos Medicine|September 8, 2023
Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS)Eveline Klinkenberg, Sian Floyd, Kwame Shanaube, et al.BMJ Open|June 16, 2022
Optimising Xpert-Ultra and culture testing to reliably measure tuberculosis prevalence in the community: findings from surveys in Zambia and South AfricaSian Floyd, Eveline Klinkenberg, Petra de Haas, et al.AIDS (London, England)|August 11, 2020
The effect of universal testing and treatment on HIV stigma in 21 communities in Zambia and South AfricaAnne L Stangl, Triantafyllos Pliakas, Tila Mainga, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2017
Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South AfricaPeter Bock, Karen Jennings, Redwaan Vermaak, et al.Vaccine|January 18, 2006
The PPD-specific T-cell clonal response in UK and Malawian subjects following BCG vaccination: a new repertoire evolves over 12 monthsAndrea R Bennett, Patricia Gorak-Stolinska, Anne Ben-Smith, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 29, 2020
HIV Stigma and Viral Suppression Among People Living With HIV in the Context of Universal Test and Treat: Analysis of Data From the HPTN 071 (PopART) Trial in Zambia and South AfricaJames R Hargreaves, Triantafyllos Pliakas, Graeme Hoddinott, et al.Infection and Immunity|February 24, 2004
Mycobacterial purified protein derivatives stimulate innate immunity: Malawians show enhanced tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-10 responses compared to those of adolescents in the United KingdomRosemary E Weir, Gillian F Black, Hazel M Dockrell, et al.The Lancet. HIV|November 4, 2022
Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysisDavid Macleod, Kwame Shanaube, Timothy Skalland, et al.Journal of the International AIDS Society|July 1, 2022
HIV drug resistance in a community-randomized trial of universal testing and treatment: HPTN 071 (PopART)Jessica M Fogel, Ethan A Wilson, Estelle Piwowar-Manning, et al.Pageof 19